DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 53 filers reported holding DERMA SCIENCES INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $59,000 | -3.3% | 11,320 | -13.7% | 0.01% | -28.6% |
| Q3 2016 | $61,000 | -44.0% | 13,120 | -52.5% | 0.01% | -48.1% |
| Q2 2016 | $109,000 | -28.3% | 27,620 | -43.7% | 0.03% | -44.9% |
| Q1 2016 | $152,000 | +16.0% | 49,035 | +71.5% | 0.05% | -38.0% |
| Q4 2015 | $131,000 | – | 28,600 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,185,632 | $11,038,000 | 5.31% |
| DAFNA Capital Management LLC | 384,794 | $3,582,000 | 2.83% |
| Consonance Capital Management LP | 1,632,627 | $15,200,000 | 1.96% |
| Broadfin Capital, LLC | 3,713,754 | $34,576,000 | 1.50% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 265,946 | $2,476,000 | 0.85% |
| Senvest Management, LLC | 1,151,926 | $10,724,000 | 0.76% |
| HealthCor Management, L.P. | 920,000 | $8,565,000 | 0.48% |
| J. Goldman & Co LP | 365,000 | $3,398,000 | 0.40% |
| Baker Brothers Advisors | 3,537,137 | $32,931,000 | 0.34% |
| Perceptive Advisors | 313,583 | $2,919,000 | 0.24% |